Clinical Trial Update: L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intravenous L-citrulline in youths with sickle cell disease presenting with vaso-occlusive crisis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Asklepion Pharmaceuticals, LLC | Conditions: Acute Vaso Occlusive Crisis (VOC) | Phase 1, Phase 2 | Status: TERMINATED